November 8, 2025 36-Month First-in-Human and 3-Month Phase I/II Trial Results Presentation (Presented at Interventional Glaucoma Consortium Meeting)
November 8, 2025 36-Month First-in-Human and 3-Month Phase I/II Trial Results Presentation (Presented at Interventional Glaucoma Consortium Meeting)
36-Month First-in-Human and 3-Month Phase I/II Trial Results Presentation (Presented at Interventional Glaucoma Consortium Meeting)
